Expression of the glucocorticoid receptor and its isoforms in relation to glucocorticoid resistance in childhood acute lymphocytic leukemia

Haematologica

Volumn 90, Issue 9, 2005, Pages 1279-1281

  Tissing, Wim J E ^a   Lauten, Melchior ^b   Meijerink, Jules P P ^a   Den Boer, Monique L ^a   Koper, Jan Willem ^c   Sonneveld, Peter ^c   Pieters, Rob ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Acute lymphoblastic leukemia; Children; Glucocorticoid; Isoforms; Resistance

Indexed keywords

GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; GLUCOCORTICOID RECEPTOR ALPHA; GLUCOCORTICOID RECEPTOR BETA; GLUCOCORTICOID RECEPTOR P; PREDNISOLONE; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ARTICLE; CHILDHOOD LEUKEMIA; HUMAN; PROGNOSIS; PROTEIN EXPRESSION;

CHILD; COHORT STUDIES; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; PREDNISOLONE; PROTEIN ISOFORMS; RECEPTORS, GLUCOCORTICOID;

EID: 25444438725     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Lauten M, Stanulla M, Zimmermann M, Weite K, Riehm H, Schrappe M. Clinical outcome of patients with childhood acute lymphoblastic leukaemia and an initial leukaemic blood blast count of less than 1000 per microliter. Klin Padiatr 2001; 213:169-74.
2. Den Boer ML, Harms DO, Pieters R, Kazemier KM, Gobel U, Korholz D, et al. Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia. J Clin Oncol 2003;21:3262-8.
3. Tissing WJ, Meijerink JP, den Boer ML, Pieters R. Molecular determinants of glucocorticoid sensitivity and resistance in acute lymphoblastic leukemia. Leukemia 2003;17:17-25.
4. Lauten M, Cario G, Asgedom G, Weite K, Schrappe M. Protein expression of the glucocorticoid receptor in childhood acute lymphoblastic leukemia. Haematologica 2003;88:1253-8.
5. Haarman EG, Kaspers GJL, Pieters R, Rottier MMA, Veerman AJP. Glucocorticoid receptor α, β and γ expression vs in vitro glucocorticod resistance in childhood leukemia. Leukemia 2004;18:530-7.
6. Stam RW, den Boer ML, Meijerink JP, Ebus ME, Peters GJ, Noordhuis P, et al. Differential mRNA expression of Ara-C-metabolizing enzymes explains Ara-C sensitivity in MLL gene-rearranged infant acute lymphoblastic leukemia. Blood 2003;101:1270-6.
7. de Lange P, Segeren CM, Koper JW, Wiemer E, Sonneveld P, Brinkmann AO, et al. Expression in hematological malignancies of a glucocorticoid receptor splice variant that augments glucocorticoid receptor-mediated effects in transfected cells. Cancer Res 2001;61:3937-41.
8. Beger C, Gerdes K, Lauten M, Tissing WJ, Fernandez-Munoz I, Schrappe M, et al. Expression and structural analysis of glucocorticoid receptor isororm γ in human leukaemia cells using an isoform-specific real-time polymerase chain reaction approach. Br J Haematol 2003; 122:245-52.
9. Holleman A, Cheok MH, den Boer ML, Yang W, Veerman AJ, Kazemier KM, et al. Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment. N Engl J Med 2004;351:533-42.
10. Lugthart S, Cheok MH, Den Boer ML, Yang W, Holleman A, Cheng C, et al. Identification of genes associated with chemotherapy crossresistance and treatment response in childhood acute lymphoblastic leukemia. Cancer Cell 2005; 7:375-86.